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Pathogenic bacteria such as M.tuberculosis have evolved several mechanisms to aid their 
intracellular survival and subvert host defenses. One of the contributing factors is thought 
to be the production and secretion of large amount of cAMP, Mycobacterial genomes 
encode a large number of adenylyl cyclases distinct in their structure and regulatory 
mechanisms. The roles of these enzymes in the physiology and pathogenesis of virulent 
mycobacteria are only now being elucidated. The roles of phosphodiesterases (PDEs), 
which serve to lower cAMP levels through degradation are, however, relatively 
unexplored. 
 
     The Rv0805 gene was previously shown to code for an active phosphodiesterase from 
Mycobacterium tuberculosis. Bioinformatics analysis revealed that orthologs of Rv0805 
were found even in eukaryotes. Biochemical and structural characterization of Rv0805 
revealed that it was a class III cAMP phosphodiesterase. Comparative genomics 
identified a close ortholog of Rv0805 in M. leprae (ML2210). The genome of  M. leprae 
Encodes only 1,604 predicted proteins and possesses the highest number of pseudogenes, 
1,116. The retention of a functional PDE, the ortholog of Rv0805, in the minimal genome 
of M. leprae is indicative of its importance in cellular physiology. Biochemical 
characterization of proteins from M. leprae and use of heterologous hosts will help 
understand this human pathogen better, since there are no tools currently available to 
genetically manipulate this bacterium. 
 
     Sequence analysis of ML2210 revealed the presence of conserved motifs and residues 
known to be critical for catalysis and unique to class III phosphodiesterases. ML2210 
shares 83% sequence identity with Rv0805 and 24% sequence identity with the 
phosphodiesterase from E. coli (cpdA). In vitro biochemical characterization of ML2210 
using non-nucleotide colorigenic and cyclic nucleotide substrates revealed that it was an 
enzymatically active phosphodiesterase. Kinetic parameters of ML2210 with respect ot 
colorigenic substrates revealed that its catalytic properties were similar to that of Rv0805. 
However, with respect to hydrolysis of 3’, 5’-cAMP, ML2210 was catalytically more 
efficient than Rv0805, suggesting that in spite of being orthologs, these enzymes have 
evolved distinct specificities at their active site. A parallel of monoclonal antibodies 
raised to Rv0805 was also used understand the differences in the biochemical properties 
of Rv0805 and ML2210 better. It was observed that only one monoclonal antibody was 
able to recognize ML2210 by ELISA and not by Western blot analysis. These results 
revealed that conformational differences between ML2210 and Rv0805 exist. 
 
     Over-expression of  ML2210  in M. smegmatis  resulted in a modest decrease in 
intracellular cAMP levels. Despite the absence of a predicted transmembrane region or a 
membrane-targeting signal, ML2210 localized to the cell envelop fraction upon over 
expression in M. smegmatis. Moreover, like Rv0805, over-expression of ML2210 also 
resulted in perturbation of the cell wall of M. smegmatis, arguing for additional cellular 
roles of  this protein. 
 
     Orthologs of Rv0805 or ML2210 are found only in slow growing mycobacteria 
suggesting that other cyclic nucleotide phosphodiesterases could regulate cAMP levels in 
fast growing mycobacteria like M. smegmatis. Since BLAST results did not retrieve an 
ortholog of Rv0805  or ML2210, COG1409 (COG database) containing Rv0805 was 
examined for the presence of other mycobacterial phosphodiesterases. Bioinformatics 
analysis identified Rv2795c as another PDE from M. tuberculosis. Sequence analysis of 
Rv2795c revealed the presence of all the motifs conserved in the class III PDEs but 
Rv2795c shared only 22% sequence identity with Rv0805 and 19% sequence identity 
with CpdA. Importantly, an ortholog of Rv2795c was identified in M. leprae. 
Interestingly. Rv2795c and its orthologs branched away from Rv0805, making it 
phylogenetically distinct and hence warranting further characterization. 
 
     Recombinant, purified MSMEG_2647 (the Rv2795c ortholog from M. smegmatis) 
was able to hydrolyze cyclic nucleotides and other phosphodiester substrates in vitro. The 
Km for colorigenic substrates was higher when compared to the Km of ML2210 or 
Rv0805 for these substrates. However, the kinetic parameters of MSMEG_2647 for 
cyclic nucleotides were comparable to those of ML2210 or Rv0805. MSMEG_2647 was 
a metal dependent enzyme and among the panel of metals tested, Mn2+ supported the 
highest in vitro catalytic activity of MSMEG_2647. Zn2+ inhibited the catalytic activity 
of MSMEG_2647. 
 
     In order to gain insight into the catalysis of MSMEG_2647, the end products of cAMP 
hydrolysis by MSMEG_2647 were analysed using reverse phase HPLC. The assay 
revealed that the end products of cyclic nucleotide hydrolysis by MSMEG_2647 were 
different when compared to the end products of hydrolysis of the same substrates by 
Rv0805 or ML2210. This suggests differences in the architecture of the active site 
residues of the mycobacterial MPEs. 
 
     A mutational anlaysis of the active site residues in MSMEG_2647 was carried out to 
identify residues involved in substrate recognition and metal coordination. Although 
Rv0805 and MSMEG_2647 shared only a 22% sequence identity, MSMEG_2647 
displayed strict conservation in the core MPE motifs. Mutation of the active residues N97 
and H98 in Rv0805 had led to an abrogation of its catalytic activity. However, 
corresponding mutations of N76A and H77A in MSMEG_2647, did not lead to a loss in 
its catalytic activity. A third mutation known to be important for the catalytic activity of 
Rv0805 (D19) was incorporated. The corresponding residue at D19 position was mutated 
to an alanine. The catalytic activity of MSMEG_2647D19AN76AH77A mutant was abrogated, 
suggesting that while the core MPE motifs are conserved between mycobacterial PDEs, 
differences in the ensemble of the active site residues contributing to their catalytic 
activity exist. Thus, at least two biochemically diverse PDE clades are found in 
mycobacterial species. 
 
     In order to decipher the function of MSMEG_2647, its expression was monitored 
during the growth of M. Smegmatis. The promoter of MSMEG_2647 displayed 
maximum activity during the logarithmic phase of  M. smegmatis growth after which its 
activity declined as M. smegmatis entered the stationary phase. However in contrast to 
this, the transcript corresponding to msmeg_2647 mRNA was found at both logarithmic 
and stationary phases. The MSMEG_2647 protein was also detected at both logarithmic 
and stationary phases of  M. smegmatis. These results suggest that additional factors may 
contribute to the stability of msmeg_2647 mRNA and protein levels. 
 
     Localization studies of MSMEG_2647 revealed that MSMEG_2647 was present in 
the cytosol as well as in the cell envelope fractions. Interestingly, over-expression of 
MSMEG_2647 did not result in a significant increase in PDE activity in various 
subcellular fractions, suggesting tight regulation on the in vivo activity in various 
subcellular fractions, suggesting tight regulation on the in vivo activity of 
MSMEG_2647. In addition, over-expression of MSMEG_2647 in M. smegmatis led to 
only a modest decrease in cAMP levels in M. smegmatis. These results suggested 
additional roles of MSMEG_2647 in the biology of mycobacteria. Overexpression of 
MSMEG_2647 peturbed the integrity of cell wall as assessed by the use of lipophillic 
indicators of cell growth, crystal violet and malachite green, and a cell wall targeting 
antibiotic, isoniazid. 
 
     Analyzing the gene neighborhood of MSMEG_2647 provided an insight into its 
putative function. It was observed that the stop codon of msmeg_2647 overlapped with 
the start codon of msmeg_2648 and stop codon of msmeg-2648 overlapped with the start 
codon of msmeg_2649. RT PCR was carried out at logarhtimic and stationary phases of 
M. smegmatis growth, which revealed that a polycistronic mRNA was being transcribed. 
These results confirmed that msmeg_2647, msmeg_2648 and msmeg_2649 were a part of 
an operon. Interestingly, these three genes as a gene cluster were confined to only those 
actinobacteria that produced mycolic acids. 
 
     An operon often encodes products that form multiprotein complexes and operate in a 
common pathway. Since there were a part of an operon, a GST pull-down approach was 
employed to test if MSMEG_2647, MSMEG_2648 and MSMEG_2649 could physically 
interact. It was observed that MSMEG_2647 interacted with MSMEG_2648 and 
MSMEG_2649. MSMEG_2648 in turn interacted with MSMEG_2649. A role for 
MSMEG_2647 as a scaffold recruiting MSMEG_2648 and MSMEG_2649 is therefore 
proposed. In turn, a complex formation with these proteins may regulate the activity of 
MSMEG_2647. 
 
     Attempts to generate a knock out of msmeg_2647 in M. smegmatis by homologous 
recombination were not successful suggesting either the gene was essential or a polar 
effect on msmeg_2648(an essential gene for the viability of M. smegmatis) may not allow 
msmeg_2647 to be deleted from the genome of M. smegmatis. 
 
     In summary, this study has identified and characterized two new phosphodiesterases 
from mycobacteria, one from the pathogenic mycobacterium, M. leprae and the other, a 
PDE from M. smegmatis that is conserved in all species of mycobacteria. Several, key 
biochemical differences were observed using biochemical and biological approaches. It 
appears that the cellular roles of mycobacterial phsophodiesterases may extend beyond 
cAMP hydrolysis, with these proteins not only regulating cell wall properties but also 
acting as scaffolding proteins in the cell. 
 
      
